Subscribe: Medical Pharmaceuticals
http://rss.prnewswire.com/industry/mtc
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announced  dec prnewswire  dec  lung cancer  market competitive  market  medical  new  pipeline review  pipeline  prnewswire  review  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Medical Pharmaceuticals

PR Newswire: Medical Pharmaceuticals



Press Releases from PR Newswire about Medical Pharmaceuticals



Published: Wed, 07 Dec 2016 04:34:33 EST

Last Build Date: Wed, 07 Dec 2016 04:01:00 EST

 



Finesse® Solutions lance le G3Lite+™ SmartController de deuxième génération destiné aux systèmes bioréacteurs à usage unique

Wed, 07 Dec 2016 04:01:00 EST

(image) SANTA CLARA, Californie, 7 décembre 2016 /PRNewswire/ -- Finesse Solutions, Inc., un fabricant de solutions de mesure et de contrôle destinées aux applications de procédés des sciences de la vie, a annoncé le lancement de son nouveau G3Lite+ SmartController pour la culture et la...



Media Files:
http://photos.prnewswire.com/prnh/20161028/433995LOGO




Finesse® Solutions startet G3Lite+™ SmartController der zweiten Generation für Einweg-Bioreaktorsysteme

Wed, 07 Dec 2016 04:01:00 EST

(image) SANTA CLARA, Kalifornien, 7. Dezember 2016 /PRNewswire/ -- Finesse Solutions, Inc., ein Hersteller von Mess- und Steuerungslösungen für Prozessanwendungen im Bereich der Biowissenschaften, gab den Start seines neuen G3Lite+ SmartController für vorgelagerte Zellkulturen und Fermentation...



Media Files:
http://photos.prnewswire.com/prnh/20161028/433995LOGO




Dr. Michael T. Parra is recognized by Continental Who's Who

Tue, 06 Dec 2016 19:05:00 EST

(image) GREENWOOD VILLAGE, Colo., Dec. 6, 2016 /PRNewswire/ -- Continental Who's Who recognizes Dr. Michael T. Parra as a Pinnacle Lifetime Member in recognition of his contributions to the Medical field. Dr. Parra brings over 30 years of experience to his role as Hematologist and Oncologist...



Media Files:
http://www.continentalwhoswho.com




Global Non-Small Cell Lung Cancer Market and Competitive Landscape Highlights - 2016

Tue, 06 Dec 2016 18:49:00 EST

(image) NEW YORK, Dec. 6, 2016 /PRNewswire/ -- The latest research from Fore Pharma, Global Non-Small Cell Lung Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Non-Small Cell Lung Cancer pipeline products, Non-Small Cell Lung Cancer epidemiology,...



Media Files:
http://www.reportlinker.com




Global Osteoporosis Market and Competitive Landscape Highlights - 2016

Tue, 06 Dec 2016 18:47:00 EST

(image) NEW YORK, Dec. 6, 2016 /PRNewswire/ -- The latest research from Fore Pharma, Global Osteoporosis Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Osteoporosis pipeline products, Osteoporosis epidemiology, Osteoporosis market valuations and forecast,...



Media Files:
http://www.reportlinker.com




Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H2 2016

Tue, 06 Dec 2016 18:31:00 EST

(image) LONDON, Dec. 6, 2016 /PRNewswire/ -- Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polyarticular Juvenile Idiopathic Arthritis (PJIA) – Pipeline Review, H2 2016,...



Media Files:
http://www.reportbuyer.com




Immunodiagnostics Market 2017-2021: US, Europe, Japan--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Tue, 06 Dec 2016 18:11:00 EST

(image) LONDON, Dec. 6, 2016 /PRNewswire/ -- Complete report PDF $37,500, DataPack (500 tables) $23,500. The report is available by geographic region, country, section, market segment, test category, and individual assay. VPGMarketResearch.com's new report is a strategic analysis of over 100...



Media Files:
http://www.reportbuyer.com




Meningioma - Pipeline Review, H2 2016

Tue, 06 Dec 2016 18:00:00 EST

(image) NEW YORK, Dec. 6, 2016 /PRNewswire/ -- Meningioma - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meningioma – Pipeline Review, H2 2016, provides an overview of the Meningioma (Oncology) pipeline landscape.A meningioma...



Media Files:
http://www.reportlinker.com




SQI Diagnostics Reports Fourth Quarter and Fiscal 2016 Results

Tue, 06 Dec 2016 17:03:00 EST

(image) Multiple Platform Sales Position SQI for Continued Growth in 2017 TORONTO, Dec. 6, 2016 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), today reported its financial and operational results for the fourth quarter and fiscal year ended September 3...



Media Files:
www.sqidiagnostics.com




ABC Acknowledges Naturopathica's Continued Support of ABC's Adopt-an-Herb Program

Tue, 06 Dec 2016 17:02:00 EST

(image) AUSTIN, Texas, Dec. 6, 2016 /PRNewswire-USNewswire/ -- The American Botanical Council (ABC) recognizes wellness company Naturopathica for its adoption of arnica (Arnica montana) through ABC's Adopt-an-Herb program. This program provides support to ABC's HerbMedPro database, a...



Media Files:
https://photos.prnewswire.com/prnvar/20100430/DC95601LOGO




Alopexx Oncology Presents Encouraging Results Of A Phase I Study Of DI-Leu16-IL2 In Relapsed/Refractory NHL At The American Society Of Hematology Annual Meeting

Tue, 06 Dec 2016 16:54:00 EST

(image) CONCORD, Mass., Dec. 6, 2016 /PRNewswire/ -- Alopexx Oncology, LLC announced data from a Phase I trial of DI-Leu16-IL2, a recombinant antibody fusion protein (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal antibody. The CD20 antibody recognizes the same target...



Media Files:
http://www.alopexx.com




Osteopathic Emergency Physician Launches New Medical Disaster Drone for Audience of Homeland Security, Global Health Organizations

Tue, 06 Dec 2016 16:30:00 EST

(image) BOLTON, Miss., Dec. 6, 2016 /PRNewswire-USNewswire/ -- Two new disaster drones delivered telemedical packages to victims and rescue personnel in a simulated mass casualty event Tuesday at John Bell Airport in Bolton, Mississippi. The technology debuted before an audience including...



Media Files:
https://photos.prnewswire.com/prnvar/20161206/446276




Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock

Tue, 06 Dec 2016 16:26:00 EST

(image) CAMBRIDGE, Mass., Dec. 6, 2016 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced that it has commenced an underwritten public offering of...



Media Files:
http://photos.prnewswire.com/prnh/20150605/221118LOGO




Ascensia implementará la Plataforma Rainmaker de Agnitio

Tue, 06 Dec 2016 16:08:00 EST

COPENHAGUE, Dinamarca, December 6, 2016 /PRNewswire/ -- Agnitio anunció hoy que Ascensia Diabetes Care ha seleccionado su plataforma de comunicación multicanal Rainmaker para uso en todo el mundo. Rainmaker es una solución de comunicación avanzada que permite a las empresas...



Viking Therapeutics Receives Orphan Drug Designation for VK0214 from the U.S. Food and Drug Administration for the Treatment of X-Linked Adrenoleukodystrophy

Tue, 06 Dec 2016 16:05:00 EST

(image) SAN DIEGO, Dec. 6, 2016 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration (FDA) has...



Media Files:
http://www.vikingtherapeutics.com




Ascensia wählt Rainmaker-Lösung von Agnitio

Tue, 06 Dec 2016 16:03:00 EST

KOPENHAGEN, Dänemark, December 6, 2016 /PRNewswire/ -- Agnitio gab heute bekannt, dass Ascensia Diabetes Care seine Multichannel-Kommunikationslösung Rainmaker für die weltweite Nutzung ausgewählt hat. Rainmaker ist eine fortschrittliche Kommunikationslösung, die es...



Thermi™ Takes Top 10 In 3 Categories In U.S. Aesthetics Industry

Tue, 06 Dec 2016 16:01:00 EST

NEW YORK, Dec. 6, 2016 /PRNewswire/ -- Thermi™, a world leader in temperature controlled radiofrequency devices, is pleased to announce recognition in top professional categories in the U.S. aesthetic industry by Aesthetic Everything, who voted Thermi™ Top 10 Aesthetic Companies, Kevin...



Xencor, Inc. Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock

Tue, 06 Dec 2016 16:01:00 EST

MONROVIA, Calif., Dec. 6, 2016 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR) today announced the completion of an underwritten public offering of 5,272,750 shares of its common stock, including 687,750 shares sold pursuant to the full exercise of an option previously granted to the...



PPJ Healthcare Enterprises to receive up to $5 million investment from GPL Ventures

Tue, 06 Dec 2016 16:01:00 EST

(image) TAMPA, Fla., Dec. 6, 2016 /PRNewswire/ -- PPJ Healthcare Enterprises, Inc. (the "Company") (OTC Pink: PPJE) announced today that on Dec. 5, 2016, it entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") with GPL Ventures LLC ("GPL"). Pursuant to the Securities...



Media Files:
http://www.ppjenterprise.com




Texas Medical Center and Australia Launch BioBridge

Tue, 06 Dec 2016 15:57:00 EST

(image) MELBOURNE, Australia, Dec. 6, 2016 /PRNewswire/ -- The Texas Medical Center (TMC) and the Health Informatics Society of Australia (HISA) today announced the establishment of a new international BioBridge, a health technology startup exchange program between Australia and the Texas Medical...



Media Files:
https://photos.prnewswire.com/prnvar/20160810/397223LOGO